Deferred Tax Assets, Valuation Allowance of Accelerate Diagnostics, Inc from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Accelerate Diagnostics, Inc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Accelerate Diagnostics, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $150,283,000, a 7.3% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Accelerate Diagnostics, Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $150,283,000 +$10,179,000 +7.3% 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q4 2023 $140,104,000 +$1,394,000 +1% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q4 2022 $138,710,000 +$6,871,000 +5.2% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $131,839,000 +$27,254,000 +26% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $104,585,000 +$22,639,000 +28% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q4 2019 $81,946,000 +$18,886,000 +30% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q4 2018 $63,060,000 +$6,206,000 +11% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q4 2017 $56,854,000 +$513,000 +0.91% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q4 2016 $56,341,000 +$18,521,000 +49% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q4 2015 $37,820,000 +$16,288,000 +76% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q4 2014 $21,532,000 +$21,112,000 +5027% 31 Dec 2014 10-K 09 Mar 2016 2015 FY
Q4 2013 $420,000 -$3,480,000 -89% 31 Dec 2013 10-K 07 Mar 2014 2013 FY
Q4 2012 $3,900,000 31 Dec 2012 10-KT 20 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.